Lamictal DC-25 (Lamotrigine Tablet) 25mg

Lamictal DC-25 (Lamotrigine 25mg) is a prescription anticonvulsant tablet used for seizure control and mood stabilization. This 30-tablet pack provides lamotrigine in dispersible form for convenient administration. Suitable for ambient storage, it supports consistent therapy management.

Strength

25mg

Pack Size

30s

Storage

Ambient

Manufacturer / TM Owner

GSK İLAÇLARI

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Lamictal DC-25 (Lamotrigine 25mg) is primarily used to reduce the frequency of seizures in epilepsy and to stabilize mood in bipolar disorder. It may also be prescribed for off-label uses such as neuropathic pain management. Patients often ask, 'what is lamotrigine 25mg used for' to understand its therapeutic role in broader treatment plans.

Side Effects

Lamictal DC-25 (Lamotrigine 25mg) works by modulating brain activity to prevent abnormal electrical signals that cause seizures or mood fluctuations. Users may notice improved daily functioning as symptoms stabilize over time. Individual responses vary, and effects are typically gradual rather than immediate.

Precautions & Warnings

Store Lamictal DC-25 at room temperature away from moisture and direct light. Keep out of reach of children and pets. Do not crush or chew the dispersible tablets unless directed. Always follow healthcare provider instructions for safe use and monitoring during therapy.

Avoid Interactions

Lamictal DC-25 may interact with other medications that affect liver enzymes, such as certain antidepressants or anticonvulsants. Alcohol and grapefruit products can influence its effects; consult a healthcare professional before combining therapies. Always disclose current medications to avoid potential interactions.

Frequently Asked Questions

Lamictal DC-25 (Lamotrigine 25mg) is used to control seizures in epilepsy and stabilize mood in bipolar disorder.

Store Lamictal DC-25 at room temperature, away from moisture and direct light, in its original packaging.

Lamictal DC-25 can be taken with or without food, but consistency in timing helps maintain stable blood levels.

No, Lamictal DC-25 (Lamotrigine 25mg) is not classified as a controlled substance.

Take the missed dose as soon as you remember, unless it’s almost time for the next dose; skip it if so.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.